# MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)

Study · id `cardio:ct-nct01154036` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01154036](<https://clinicaltrials.gov/study/NCT01154036>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01154036

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1547 participants.

## Technical summary

Registry record NCT01154036. Randomized; double masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2014-02-12.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1547 participants (enrolled count; ClinicalTrials.gov record NCT01154036, source copy `cardio:ctgov-nct01154036-2022-02-09`, retrieved 2026-10-31)
- Start date: 2010-07 (registry gives no type) (ClinicalTrials.gov record NCT01154036, source copy `cardio:ctgov-nct01154036-2022-02-09`, retrieved 2026-10-31)
- Primary completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01154036, source copy `cardio:ctgov-nct01154036-2022-02-09`, retrieved 2026-10-31)
- Completion: 2012-10 (actual) (ClinicalTrials.gov record NCT01154036, source copy `cardio:ctgov-nct01154036-2022-02-09`, retrieved 2026-10-31)
- Results first posted: 2014-02-12 (ClinicalTrials.gov record NCT01154036, source copy `cardio:ctgov-nct01154036-2022-02-09`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01154036-2022-02-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)
- Condition: Hypercholesterolemia
- Intervention (Drug): ezetimibe 10 mg
- Intervention (Drug): atorvastatin
- Intervention (Drug): Comparator: rosuvastatin
- Lead sponsor: Organon and Co
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry lists this organization as the lead sponsor: Organon and Co (`cardio:org-organon-and-co`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemia (`cardio:pubmed-24063830`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey (`cardio:pubmed-25985907`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 52a87758bccc2713612cb00a9198874d22479174f0a49ab429ba5925a4d4e6f5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
